(Q34326169)

English

Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms (English)

1 reference

Europe PubMed Central

1 August 2017

prostate cancer screening

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

object named as

John L Gore

2

0 references

author name string

Roman Gulati

1

1 reference

Europe PubMed Central

1 August 2017

Ruth Etzioni

3

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

1 February 2013

1 reference

Europe PubMed Central

1 August 2017

Annals of Internal Medicine

1 reference

Europe PubMed Central

1 August 2017

158

1 reference

Europe PubMed Central

1 August 2017

3

1 reference

Europe PubMed Central

1 August 2017

145-153

1 reference

Europe PubMed Central

1 August 2017

Quality-of-life effects of prostate-specific antigen screening.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

The impact of PLCO control arm contamination on perceived PSA screening efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Prostate-cancer mortality at 11 years of follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Long-term projections of the harm-benefit trade-off in prostate cancer screening are more favorable than previous short-term estimates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

How does early detection by screening affect disease progression? Modeling estimated benefits in prostate cancer screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

What is the true number needed to screen and treat to save a life with prostate-specific antigen testing?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Comorbidity and mortality results from a randomized prostate cancer screening trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Calibrating disease progression models using population data: a critical precursor to policy development in cancer control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Simulation modeling of health care policy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

American Cancer Society guideline for the early detection of prostate cancer: update 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

NCCN clinical practice guidelines in oncology: prostate cancer early detection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Prostate cancer: estimating the benefits of PSA screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Screening and prostate-cancer mortality in a randomized European study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Mortality results from a randomized prostate-cancer screening trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Viewpoint: expanding prostate cancer screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Viewpoint: limiting prostate cancer screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

6 July 2018

Quality of life and guidelines for PSA screening.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

27 October 2018

The impact of interscreening interval and age on prostate cancer screening with prostate-specific antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

27 October 2018

Radical prostatectomy versus watchful waiting in early prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

27 October 2018

Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

27 October 2018

Contamination by opportunistic screening in the European Randomized Study of Prostate Cancer Screening.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

27 October 2018

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

27 October 2018

Modeling for health care and other policy decisions: uses, roles, and validity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3738063

27 October 2018

Commentary on "prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: Mortality results after 13 years of follow-up". Andriole GL, Crawford ED, Grubb RL III, Buys SS, Chia D, Church TR, Fouad MN,

1 reference

https://pubmed.ncbi.nlm.nih.gov/23381039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A population model of prostate cancer incidence

1 reference

https://pubmed.ncbi.nlm.nih.gov/23381039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A piece of my mind. Making the call

1 reference

https://pubmed.ncbi.nlm.nih.gov/23381039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modeling the outcomes of prostate cancer screening

1 reference

https://pubmed.ncbi.nlm.nih.gov/23381039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23381039

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.7326/0003-4819-158-3-201302050-00003

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34326169&oldid=1958458917"